Loading
NASDAQHealthcareMedical - Pharmaceuticals
Latest quote
$0.7902
−$0.0586 · -6.90%
Pomdoctor Limited, operating through its various divisions, runs an e-commerce platform for the direct sale of pharmaceutical products to consumers. The company is actively developing an online healthcare services platform specifically designed for managing long-term illnesses within the Chinese market. Its primary emphasis is on chronic disease care and pharmaceutical provision, facilitating a digital portal that connects patients with medical professionals and essential medications. Pomdoctor's operations largely encompass both a virtual hospital model and a comprehensive pharmaceutical supply chain, thus linking individual users, pharmacies, distributors, medical experts, and other healthcare stakeholders. This enterprise was established in 2010 and is headquartered in Guangzhou, China.
Latest quote
$0.7902
−$0.0586 · -6.90%
After-hours
$0.7901
−$0.0001 · -0.01%
Oct 8, 7:30 PM ET
Regular session · ET · Market data may be delayed.
Pomdoctor Limited, operating through its various divisions, runs an e-commerce platform for the direct sale of pharmaceutical products to consumers. The company is actively developing an online healthcare services platform specifically designed for managing long-term illnesses within the Chinese market. Its primary emphasis is on chronic disease care and pharmaceutical provision, facilitating a digital portal that connects patients with medical professionals and essential medications. Pomdoctor's operations largely encompass both a virtual hospital model and a comprehensive pharmaceutical supply chain, thus linking individual users, pharmacies, distributors, medical experts, and other healthcare stakeholders. This enterprise was established in 2010 and is headquartered in Guangzhou, China.
Day range
Current $0.7902
52-week range
Current $0.7902
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
73
Undervalued
Sentiment
46
Mixed
Risk
80
High Risk
Momentum
17
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Pomdoctor Limited, operating through its various divisions, runs an e-commerce platform for the direct sale of pharmaceutical products to consumers. The company is actively developing an online healthcare services platform specifically designed for managing long-term illnesses within the Chinese market. Its primary emphasis is on chronic disease care and pharmaceutical provision, facilitating a digital portal that connects patients with medical professionals and essential medications. Pomdoctor's operations largely encompass both a virtual hospital model and a comprehensive pharmaceutical supply chain, thus linking individual users, pharmacies, distributors, medical experts, and other healthcare stakeholders. This enterprise was established in 2010 and is headquartered in Guangzhou, China.
Day range
Current $0.7902
52-week range
Current $0.7902
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 399.91M CNY | 342.56M CNY | 304.85M CNY | 245.22M CNY | 215.38M CNY |
| Cost of goods sold | 347.63M CNY | 294.86M CNY | 266.13M CNY | 190.36M CNY | 162.88M CNY |
| Gross profit | 52.28M CNY | 47.69M CNY | 38.72M CNY | 54.86M CNY | 52.51M CNY |
| Research and development | 12.86M CNY | 3M CNY | 3.37M CNY | 3.59M CNY | 4.28M CNY |
| Selling, general, and administrative | 155.94M CNY | 68.24M CNY | 55.99M CNY | 54.87M CNY | 102.95M CNY |
| Operating expenses | 168.66M CNY | 73.49M CNY | 60.97M CNY | 58.46M CNY | 132.18M CNY |
| Interest expense | 12.89M CNY | 12.96M CNY | 13.85M CNY | 16.02M CNY | 16.29M CNY |
| Depreciation and amortization | 149.31K CNY | 134.51K CNY | 112.09K CNY | — | 21.32M CNY |
| Operating income | −116.37M CNY | −25.79M CNY | −22.25M CNY | −3.59M CNY | −79.67M CNY |
| Net income | −212.58M CNY | −143.36M CNY | −145.39M CNY | −125.51M CNY | −188.4M CNY |
Company facts updated Oct 9, 2026.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
